@wiki 439 2008-09-03T03:19:35Z @wiki::98/ 2008-09-03 2008-09-03T03:19:35Z

  A Pricing Strategy for Combination Products (Medical Device Link, May/June 2004)

@wiki::97/ 2008-08-28 2008-08-28T16:17:45Z

Per American Academy of Family Practice Management     Table 6A: New Diagnosis Codes Code               Description 040.41          Infant botulism 040.42          Wound botulism 058.10          Roseola infantum, unspecified 058.11          Roseola infantum due to human herpesvirus 6 058.12          Roseola infantum due to human herpesvirus 7 058.21          Human herpesvirus 6 encephalitis 058.29          Other human herpesvirus encephalitis 058.81          Human herpesvirus 6 infection 058.82          Human herpesvirus 7 infection 058.89          Other human herpesvirus infection 079.83          Parvovirus B19 200.30          Marginal zone lymphoma, unspecified site, extranodal and solid organ sites 200.31          Marginal zone lymphoma, lymph nodes of head, face, and neck 200.32          Marginal zone lymphoma, intrathoracic lymph nodes 200.33          Marginal zone lymphoma, intraabdominal lymph nodes 200.34          Marginal zone lymphoma, lymph nodes of axilla and upper limb 200.35          Marginal zone lymphoma, lymph nodes of inguinal region and lower limb 200.36          Marginal zone lymphoma, intrapelvic lymph nodes 200.37          Marginal zone lymphoma, spleen 200.38          Marginal zone lymphoma, lymph nodes of multiple sites 200.40          Mantle cell lymphoma, unspecified site, extranodal and solid organ sites 200.41          Mantle cell lymphoma, lymph nodes of head, face, and neck 200.42          Mantle cell lymphoma, intrathoracic lymph nodes 200.43          Mantle cell lymphoma, intra-abdominal lymph nodes 200.44          Mantle cell lymphoma, lymph nodes of axilla and upper limb 200.45          Mantle cell lymphoma, lymph nodes of inguinal region and lower limb 200.46          Mantle cell lymphoma, intrapelvic lymph nodes 200.47          Mantle cell lymphoma, spleen 200.48          Mantle cell lymphoma, lymph nodes of multiple sites 200.50          Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites 200.51          Primary central nervous system lymphoma, lymph nodes of head, face, and neck 200.52          Primary central nervous system lymphoma, intrathoracic lymph nodes 200.53          Primary central nervous system lymphoma, intra-abdominal lymph nodes 200.54          Primary central nervous system lymphoma, lymph nodes of axilla and upper limb 200.55          Primary central nervous system lymphoma, lymph nodes of inguinal region and lower limb 200.56          Primary central nervous system lymphoma, intrapelvic lymph nodes 200.57          Primary central nervous system lymphoma, spleen 200.58          Primary central nervous system lymphoma, lymph nodes of multiple sites 200.60          Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites 200.61          Anaplastic large cell lymphoma, lymph nodes of head, face, and neck 200.62          Anaplastic large cell lymphoma, intrathoracic lymph nodes 200.63          Anaplastic large cell lymphoma, intra-abdominal lymph nodes 200.64          Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb 200.65          Anaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb 200.66          Anaplastic large cell lymphoma, intrapelvic lymph nodes 200.67          Anaplastic large cell lymphoma, spleen 200.68          Anaplastic large cell lymphoma, lymph nodes of multiple sites 200.70          Large cell lymphoma, unspecified site, extranodal and solid organ sites 200.71          Large cell lymphoma, lymph nodes of head, face, and neck 200.72          Large cell lymphoma, intrathoracic lymph nodes 200.73          Large cell lymphoma, intra-abdominal lymph nodes 200.74          Large cell lymphoma, lymph nodes of axilla and upper limb 200.75          Large cell lymphoma, lymph nodes of inguinal region and lower limb 200.76          Large cell lymphoma, intrapelvic lymph nodes 200.77          Large cell lymphoma, spleen 200.78          Large cell lymphoma, lymph nodes of multiple sites 202.70          Peripheral T cell lymphoma, unspecified site, extranodal and solid organ sites 202.71          Peripheral T cell lymphoma, lymph nodes of head, face, and neck 202.72          Peripheral T cell lymphoma, intrathoracic lymph nodes 202.73          Peripheral T cell lymphoma, intra-abdominal lymph nodes 202.74          Peripheral T cell lymphoma, lymph nodes of axilla and upper limb 202.75          Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb 202.76          Peripheral T cell lymphoma, intrapelvic lymph nodes 202.77          Peripheral T cell lymphoma, spleen 202.78          Peripheral T cell lymphoma, lymph nodes of multiple sites 233.30          Carcinoma in situ, unspecified female genital organ 233.31          Carcinoma in situ,vagina 233.32          Carcinoma in situ,vulva 233.39          Carcinoma in situ, other female genital organ 255.41          Glucocorticoid deficiency 255.42          Mineralocorticoid deficiency 258.01          Multiple endocrine neoplasia [MEN] type I 258.02          Multiple endocrine neoplasia [MEN] type IIA 258.03          Multiple endocrine neoplasia [MEN] type IIB 284.81          Red cell aplasia (acquired)(adult)(with thymoma) 284.89          Other specified aplastic anemias 288.66          Bandemia 315.34          Speech and language developmental delay due to hearing loss 331.5            Idiopathic normal pressure hydrocephalus (INPH) 359.21          Myotonic muscular dystrophy 359.22          Myotonia congenital 359.23          Myotonic chondrodystrophy 359.24          Drug induced myotonia 359.29          Other specified myotonic disorder 364.81          Floppy iris syndrome 364.89          Other disorders of iris and ciliary body 388.45          Acquired auditory processing disorder 389.05          Conductive hearing loss, unilateral 389.06          Conductive hearing loss, bilateral 389.13          Neural hearing loss, unilateral 389.17          Sensory hearing loss, unilateral 389.20          Mixed hearing loss, unspecified 389.21          Mixed hearing loss, unilateral 389.22          Mixed hearing loss, bilateral 414.2            Chronic total occlusion of coronary artery 415.12          Septic pulmonary embolism 423.3            Cardiac tamponade 440.4            Chronic total occlusion of artery of the extremities 449              Septic arterial embolism 488              Influenza due to identified avian influenza virus 525.71          Osseointegration failure of dental implant 525.72          Post-osseointegration biological failure of dental implant 525.73          Post-osseointegration mechanical failure of dental implant 525.79          Other endosseous dental implant failure 569.43          Anal sphincter tear (healed) (old) 624.01          Vulvar intraepithelial neoplasia I [VIN I] 624.02          Vulvar intraepithelial neoplasia II [VIN II] 624.09          Other dystrophy of vulva 664.60          Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, unspecified as to episode of care or not applicable 664.61          Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, delivered, with or without mention of antepartum condition 664.64          Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, postpartum condition or complication 733.45          Aseptic necrosis of bone, jaw 787.20          Dysphagia, unspecified 787.21          Dysphagia, oral phase 787.22          Dysphagia, oropharyngeal phase 787.23          Dysphagia, pharyngeal phase 787.24          Dysphagia, pharyngoesophageal phase 787.29          Other dysphagia 789.51          Malignant ascites 789.59          Other ascites 999.31          Infection due to central venous catheter 999.39          Infection following other infusion, injection, transfusion, or vaccination V12.53          Personal history of sudden cardiac arrest V12.54          Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits V13.22          Personal history of cervical dysplasia V16.52          Family history of malignant neoplasm, bladder V17.41          Family history of sudden cardiac death (SCD) V17.49          Family history of other cardiovascular diseases V18.11          Family history of multiple endocrine neoplasia [MEN] syndrome V18.19          Family history of other endocrine and metabolic diseases V25.04          Counseling and instruction in natural family planning to avoid pregnancy V26.41          Procreative counseling and advice using natural family planning V26.49          Other procreative management, counseling and advice V26.81          Encounter for assisted reproductive fertility procedure cycle V26.89          Other specified procreative management V49.85          Dual sensory impairment V68.01          Disability examination V68.09          Other issue of medical certificates V72.12          Encounter for hearing conservation and treatment V73.81          Special screening examination, Human papillomavirus (HPV) V84.81          Genetic susceptibility to multiple endocrine neoplasia [MEN] V84.89          Genetic susceptibility to other disease  

@wiki::96/ 2008-08-28 2008-08-28T16:09:31Z

Per American Academy of Professional Coders   New 2009 ICD-9-CM Codes 038.12 Methicillin resistant Staphylococcus aureus septicemia 041.12 Methicillin-resistant Staphylococcus aureus (MRSA) 046.11 Varient Creutzfeldt-Jakob disease 046.19 Other and unspecified Creutzfeldt-Jakob disease 046.71 Gerstmann-Sträussler-Scheinker syndrome 046.72 Fatal familial insomnia 046.79 Other and unspecified prion disease of central nervous system 051.01 Cowpox 051.02 Vaccinia not from vaccination 059.00 Orthopoxvirus infection, unspecified 059.01 Monkeypox 059.09 Other orthopoxvirus infections 059.10 Parapoxvirus infection, unspecified 059.11 Bovine stomatitis 059.12 Sealpox 059.19 Other parapoxvirus infections 059.20 Yatapoxvirus infection, unspecified 059.21 Tanapox 059.22 Yaba monkey tumor virus 059.8   Other poxvirus infections 059.9   Poxvirus infections, unspecified 078.12 Plantar wart 136.21 Specific infection due to acanthamoeba 136.29 Other specific infections by free-living amebae 199.2   Malignant neoplasm associated with transplant organ 203.02 Multiple myeloma, in relapse 203.12 Plasma cell leukemia, in relapse 203.82 Other immunoproliferative neoplasms, in relapse 204.02 Acute lymphoid leukemia, in relapse 204.12 Chronic lymphoid leukemia, in relapse 204.22 Subacute lymphoid leukemia, in relapse 204.82 Other lymphoid leukemia, in relapse 204.92 Unspecified lymphoid leukemia, in relapse 205.02 Acute myeloid leukemia, in relapse 205.12 Chronic myeloid leukemia, in relapse 205.22 Subacute myeloid leukemia, in relapse 205.32 Myeloid sarcoma, in relapse 205.82 Other myeloid leukemia, in relapse 205.92 Unspecified myeloid leukemia, in relapse 208.92 Unspecified leukemia, in relapse 206.02 Acute monocytic leukemia, in relapse 206.12 Chronic monocytic leukemia, in relapse 206.22 Subacute monocytic leukemia, in relapse 206.82 Other monocytic leukemia, in relapse 206.92 Unspecified monocytic leukemia, in relapse 207.02 Acute erythremia and erythroleukemia, in relapse 207.12 Chronic erythremia, in relapse 207.22 Megakaryocytic leukemia, in relapse 207.82 Other specified leukemia, in relapse 208.02 Acute leukemia of unspecified cell type, in relapse 208.12 Chronic leukemia of unspecified cell type, in relapse 208.22 Subacute leukemia of unspecified cell type, in relapse 208.82 Other leukemia of unspecified cell type, in relapse 209.00 Malignant carcinoid tumor of the small intestine, unspecified portion 209.01 Malignant carcinoid tumor of the duodenum 209.02 Malignant carcinoid tumor of the jejunum 209.03 Malignant carcinoid tumor of the ileum 209.10 Malignant carcinoid tumor of the large intestine, unspecified portion 209.11 Malignant carcinoid tumor of the appendix 209.12 Malignant carcinoid tumor of the cecum 209.13 Malignant carcinoid tumor of the ascending colon 209.14 Malignant carcinoid tumor of the transverse colon 209.15 Malignant carcinoid tumor of the descending colon 209.16 Malignant carcinoid tumor of the sigmoid colon 209.17 Malignant carcinoid tumor of the rectum 209.20 Malignant carcinoid tumor of unknown primary site 209.21 Malignant carcinoid tumor of the bronchus and lung 209.22 Malignant carcinoid tumor of the thymus 209.23 Malignant carcinoid tumor of the stomach 209.24 Malignant carcinoid tumor of the kidney 209.25 Malignant carcinoid tumor of foregut, NOS 209.26 Malignant carcinoid tumor of midgut, NOS 209.27 Malignant carcinoid tumor of hindgut, NOS 209.29 Malignant carcinoid tumor of other sites 209.30 Malignant poorly differentiated neuroendocrine carcinoma, any site 209.40 Benign carcinoid tumor of the small intestine, unspecified portion 209.41 Benign carcinoid tumor of the duodenum 209.42 Benign carcinoid tumor of the jejunum 209.43 Benign carcinoid tumor of the ileum 209.50 Benign carcinoid tumor of the large intestine, unspecified portion 209.51 Benign carcinoid tumor of the appendix 209.52 Benign carcinoid tumor of the cecum 209.53 Benign carcinoid tumor of the ascending colon 209.54 Benign carcinoid tumor of the transverse colon 209.55 Benign carcinoid tumor of the descending colon 209.56 Benign carcinoid tumor of the sigmoid colon 209.57 Benign carcinoid tumor of the rectum 209.60 Benign carcinoid tumor of unknown primary site 209.61 Benign carcinoid tumor of the bronchus and lung 209.62 Benign carcinoid tumor of the thymus 209.63 Benign carcinoid tumor of the stomach 209.64 Benign carcinoid tumor of the kidney 209.65 Benign carcinoid tumor of foregut, NOS 209.66 Benign carcinoid tumor of midgut, NOS 209.67 Benign carcinoid tumor of hindgut, NOS 209.69 Benign carcinoid tumor of other sites 238.77 Post-transplant lymphoproliferative disorder (PTLD) 249.00 Secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 249.01 Secondary diabetes mellitus without mention of complication, uncontrolled 249.10 Secondary diabetes mellitus with ketoacidosis, not stated as uncontrolled, or unspecified 249.11 Secondary diabetes mellitus with ketoacidosis, uncontrolled 249.20 Secondary diabetes mellitus with hyperosmolarity, not stated as uncontrolled, or unspecified 249.21 Secondary diabetes mellitus with hyperosmolarity, uncontrolled 249.30 Secondary diabetes mellitus with other coma, not stated as uncontrolled, or unspecified 249.31 Secondary diabetes mellitus with other coma, uncontrolled 249.40 Secondary diabetes mellitus with renal manifestations, not stated as uncontrolled, or unspecified 249.41 Secondary diabetes mellitus with renal manifestations, uncontrolled 249.50 Secondary diabetes mellitus with ophthalmic manifestations, not stated as uncontrolled, or unspecified 249.51 Secondary diabetes mellitus with ophthalmic manifestations, uncontrolled 249.60 Secondary diabetes mellitus with neurological manifestations, not stated as uncontrolled, or unspecified 249.61 Secondary diabetes mellitus with neurological manifestations, uncontrolled 249.70 Secondary diabetes mellitus with peripheral circulatory disorders, not stated as uncontrolled, or unspecified 249.71 Secondary diabetes mellitus with peripheral circulatory disorders, uncontrolled 249.80 Secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified 249.81 Secondary diabetes mellitus with other specified manifestations, uncontrolled 249.90 Secondary diabetes mellitus with unspecified complication, not stated as uncontrolled, or unspecified 249.91 Secondary diabetes mellitus with unspecified complication, uncontrolled 259.50 Androgen insensitivity, unspecified 259.51 Androgen insensitivity syndrome 259.52 Partial androgen insensitivity 275.5   Hungry bone syndrome 279.50 Graft-versus-host disease, unspecified 279.51 Acute graft-versus-host disease 279.52 Chronic graft-versus-host disease 279.53 Acute on chronic graft-versus-host disease 289.84 Heparin-induced thrombocytopenia (HIT) 337.00 Idiopathic peripheral autonomic neuropathy, unspecified 337.01 Carotid sinus syndrome 337.09 Other idiopathic peripheral autonomic neuropathy 339.00 Cluster headache syndrome, unspecified 339.01 Episodic cluster headache 339.02 Chronic cluster headache 339.03 Episodic paroxysmal hemicrania 339.04 Chronic paroxysmal hemicrania 339.05 Short lasting unilateral neuralgiform headache with conjunctival injection and tearing 339.09 Other trigeminal autonomic cephalgias 339.10 Tension type headache, unspecified 339.11 Episodic tension type headache 339.12 Chronic tension type headache 339.20 Post-traumatic headache, unspecified 339.21 Acute post-traumatic headache 339.22 Chronic post-traumatic headache 339.3   Drug induced headache, not elsewhere classified 339.41 Hemicrania continua 339.42 New daily persistent headache 339.43 Primary thunderclap headache 339.44 Other complicated headache syndrome 339.81 Hypnic headache 339.82 Headache associated with sexual activity 339.83 Primary cough headache 339.84 Primary exertional headache 339.85 Primary stabbing headache 339.89 Other headache syndromes 346.02 Migraine with aura, without mention of intractable migraine with status migrainosus 346.03 Migraine with aura, with intractable migraine, so stated, with status migrainosus 346.12 Migraine without aura, without mention of intractable migraine with status migrainosus 346.13 Migraine without aura, with intractable migraine, so stated, with status migrainosus 346.22 Variants of migraine, not elsewhere classified, without mention of intractable migraine with status migrainosus 346.23 Variants of migraine, not elsewhere classified, with intractable migraine, so stated, with status migrainosus 346.30 Hemiplegic migraine, without mention of intractable migraine without mention of status migrainosus 346.31 Hemiplegic migraine, with intractable migraine, so stated, without mention of status migrainosus 346.32 Hemiplegic migraine, without mention of intractable migraine with status migrainosus 346.33 Hemiplegic migraine, with intractable migraine, so stated, with status migrainosus 346.40 Menstrual migraine, without mention of intractable migraine without mention of status migrainosus 346.41 Menstrual migraine, with intractable migraine, so stated, without mention of status migrainosus 346.42 Menstrual migraine, without mention of intractable migraine with status migrainosus 346.43 Menstrual migraine, with intractable migraine, so stated, with status migrainosus 346.50 Persistent migraine aura without cerebral infarction, without mention of intractable migraine without mention of status migrainosus 346.51 Persistent migraine aura without cerebral infarction, with intractable migraine, so stated, without mention of status migrainosus 346.52 Persistent migraine aura without cerebral infarction, without mention of intractable migraine with status migrainosus 346.53 Persistent migraine aura without cerebral infarction, with intractable migraine, so stated, with status migrainosus 346.60 Persistent migraine aura with cerebral infarction, without mention of intractable migraine without mention of status migrainosus 346.61 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, without mention of status migrainosus 346.62 Persistent migraine aura with cerebral infarction, without mention of intractable migraine with status migrainosus 346.63 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, with status migrainosus 346.70 Chronic migraine without aura, without mention of intractable migraine without mention of status migrainosus 346.71 Chronic migraine without aura, with intractable migraine, so stated, without mention of status migrainosus 346.72 Chronic migraine without aura, without mention of intractable migraine with status migrainosus 346.73 Chronic migraine without aura, with intractable migraine, so stated, with status migrainosus 346.82 Other forms of migraine, without mention of intractable migraine with status migrainosus 346.83 Other forms of migraine, with intractable migraine, so stated, with status migrainosus 346.92 Unspecified migraine, without mention of intractable migraine with status migrainosus 346.93 Unspecified migraine, with intractable migraine, so stated, with status migrainosus 362.20 Retinopathy of prematurity, unspecified 362.22 Retinopathy of prematurity, stage 0 362.23 Retinopathy of prematurity, stage 1 362.24 Retinopathy of prematurity, stage 2 362.25 Retinopathy of prematurity, stage 3 362.26 Retinopathy of prematurity, stage 4 362.27 Retinopathy of prematurity, stage 5 364.82 Plateau iris syndrome 372.34 Pingueculitis 414.3   Coronary atherosclerosis due to lipid rich plaque 511.81 Malignant pleural effusion 511.89 Other specified forms of effusion, except tuberculous 530.13 Eosinophilic esophagitis 535.70 Eosinophilic gastritis without mention of hemorrhage 535.71 Eosinophilic gastritis with hemorrhage 558.41 Eosinophilic gastroenteritis 558.42 Eosinophilic colitis 569.44 Dysplasia of anus 571.42 Autoimmune hepatitis 599.70 Hematuria, unspecified 599.71 Gross hematuria 599.72 Microscopic hematuria 611.81 Ptosis of breast 611.82 Hypoplasia of breast 611.83 Capsular contracture of breast implant 611.89 Other specified disorders of breast 612.0 Deformity of reconstructed breast 612.1 Disproportion of reconstructed breast 625.70 Vulvodynia, unspecified 625.71 Vulvar vestibulitis 625.79 Other vulvodynia 649.70 Cervical shortening, unspecified as to episode of care or not applicable 649.71 Cervical shortening, delivered, with or without mention of antepartum condition 649.73 Cervical shortening, antepartum condition or complication 678.00 Fetal hematologic conditions, unspecified as to episode of care or not applicable 678.01 Fetal hematologic conditions, delivered, with or without mention of antepartum condition 678.03 Fetal hematologic conditions, antepartum condition or complication   678.10 Fetal conjoined twins, unspecified as to episode of care or not applicable 678.11 Fetal conjoined twins, delivered, with or without mention of antepartum condition 678.13 Fetal conjoined twins, antepartum condition or complication 679.00 Maternal complications from in utero procedure, unspecified as to episode of care or not applicable 679.01 Maternal complications from in utero procedure, delivered, with or without mention of antepartum condition 679.02 Maternal complications from in utero procedure, delivered, with mention of postpartum complication 679.03 Maternal complications from in utero procedure, antepartum condition or complication 679.04 Maternal complications from in utero procedure, postpartum condition or complication 679.10 Fetal complications from in utero procedures, unspecified as to episode of care or not applicable 679.11 Fetal complications from in utero procedures, delivered, with or without mention of antepartum condition 679.12 Fetal complications from in utero procedures, delivered, with mention of postpartum complication 679.13 Fetal complications from in utero procedures, antepartum condition or complication 679.14 Fetal complications from in utero procedures, postpartum condition or complication 695.10 Erythema multiforme, unspecified 695.11 Erythema multiforme minor 695.12 Erythema multiforme major 695.13 Stevens-Johnson syndrome 695.14 Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome 695.15 Toxic epidermal necrolysis 695.19 Other erythema multiforme 695.50 Exfoliation due to erythematous condition involving less than 10 percent of body surface 695.51 Exfoliation due to erythematous condition involving 10-19 percent of body surface 695.52 Exfoliation due to erythematous condition involving 20-29 percent of body surface 695.53 Exfoliation due to erythematous condition involving 30-39 percent of body surface 695.54 Exfoliation due to erythematous condition involving 40-49 percent of body surface 695.55 Exfoliation due to erythematous condition involving 50-59 percent of body surface 695.56 Exfoliation due to erythematous condition involving 60-69 percent of body surface 695.57 Exfoliation due to erythematous condition involving 70-79 percent of body surface 695.58 Exfoliation due to erythematous condition involving 80-89 percent of body surface 695.59 Exfoliation due to erythematous condition involving 90 percent or more of body surface 707.20 Pressure ulcer, unspecified stage 707.21 Pressure ulcer, stage I 707.22 Pressure ulcer, stage II 707.23 Pressure ulcer, stage III 707.24 Pressure ulcer, stage IV 707.25 Pressure ulcer, unstageable 729.90 Disorders of soft tissue, unspecified 729.91 Post-traumatic seroma 729.92 Nontraumatic hematoma of soft tissue 729.99 Other disorders of soft tissue 760.61 Newborn affected by amniocentesis 760.62 Newborn affected by other in utero procedure 760.63 Newborn affected by other surgical operations on mother during pregnancy 760.64 Newborn affected by previous surgical procedure on mother not associated with pregnancy 777.50 Necrotizing enterocolitis in newborn, unspecified 777.51 Stage I necrotizing enterocolitis in newborn 777.52 Stage II necrotizing enterocolitis in newborn 777.53 Stage III necrotizing enterocolitis in newborn 780.60 Fever, unspecified 780.61 Fever presenting with conditions classified elsewhere 780.62 Postprocedural fever 780.63 Postvaccination fever 780.64 Chills (without fever) 780.65 Hypothermia not associated with low environmental temperature 780.72 Functional quadriplegia 788.91 Functional urinary incontinence 788.99 Other symptoms involving urinary system 795.07 Satisfactory cervical smear but lacking transformation zone 795.10 Abnormal glandular Papanicolaou smear of vagina 795.11 Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US) 795.12 Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H) 795.13 Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL) 795.14 Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL) 795.15 Vaginal high risk human papillomavirus (HPV) DNA test positive 795.16 Papanicolaou smear of vagina with cytologic evidence of malignancy 795.18 Unsatisfactory vaginal cytology smear 795.19 Other abnormal Papanicolaou smear of vagina and vaginal HPV 796.70 Abnormal glandular Papanicolaou smear of anus 796.71 Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US) 796.72 Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H) 796.73 Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL) 796.74 Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL) 796.75 Anal high risk human papillomavirus (HPV) DNA test positive 796.76 Papanicolaou smear of anus with cytologic evidence of malignancy 796.77 Satisfactory anal smear but lacking transformation zone 796.78 Unsatisfactory anal cytology smear 796.79 Other abnormal Papanicolaou smear of anus and anal HPV 997.31 Ventilator associated pneumonia 997.39 Other respiratory complications 998.30 Disruption of wound, unspecified 998.33 Disruption of traumatic wound repair 999.81 Extravasation of vesicant chemotherapy 999.82 Extravasation of other vesicant agent 999.88 Other infusion reaction 999.89 Other transfusion reaction V02.53 Methicillin susceptible Staphylococcus aureus MSSA colonization V02.54 Methicillin resistant Staphylococcus aureus MRSA colonization V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs) V07.52 Prophylactic use of aromatase inhibitors V07.59 Prophylactic use of other agents affecting estrogen receptors and estrogen levels V12.04 Methicillin resistant Staphylococcus aureus V13.51 Personal history of pathologic fracture V13.52 Personal history of stress fracture V13.59 Personal history of other musculoskeletal disorders V15.21 Personal history of undergoing in utero procedure during pregnancy V15.22 Personal history of undergoing in utero procedure while a fetus V15.29 Personal history of surgery to other organs V15.51 Personal history of traumatic fracture V15.59 Personal history of other injury V23.85 Pregnancy resulting from assisted reproductive technology V23.86 Pregnancy with history of in utero procedure during previous pregnancy V28.81 Encounter for fetal anatomic survey V28.82 Encounter for screening for risk of pre-term labor V28.89 Other specified antenatal screening V45.11 Renal dialysis status V45.12 Noncompliance with renal dialysis V45.87 Transplanted organ removal status V45.88 Status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility V46.3 Wheelchair dependence V51.0   Encounter for breast reconstruction following mastectomy V51.8   Other aftercare involving the use of plastic surgery V61.01 Family disruption due to family member on military deployment             Individual or family affected by other family member being on deployment V61.02 Family disruption due to return of family member from military deployment             Individual or family affected by other family member having returned from deployment (current or past conflict) V61.03 Family disruption due to divorce or legal separation V61.04 Family disruption due to parent-child estrangement V61.05 Family disruption due to child in welfare custody V61.06 Family disruption due to child in foster care or in care of non-parental family member V61.09 Other family disruption V62.21 Personal current military deployment status V62.22 Personal history of return from military deployment V62.29 Other occupational circumstances or maladjustment V87.01 Contact with and (suspected) exposure to arsenic V87.09 Contact with and (suspected) exposure to other hazardous metals V87.11 Contact with and (suspected) exposure to aromatic amines V87.12 Contact with and (suspected) exposure to benzene V87.19 Contact with and (suspected) exposure to other hazardous aromatic compounds V87.2   Contact with and (suspected) exposure to other potentially hazardous chemicals V87.3   Contact with and (suspected) exposure to other potentially hazardous substances V87.31 Contact with and (suspected) exposure to mold V87.39 Contact with and (suspected) exposure to other potentially hazardous substances V87.41 Personal history of antineoplastic chemotherapy V87.42 Personal history of monoclonal drug therapy V87.49 Personal history of other drug therapy V88.01 Acquired absence of both cervix and uterus V88.02 Acquired absence of uterus with remaining cervical stump V88.03 Acquired absence of cervix with remaining uterus V89.01 Suspected problem with amniotic cavity and membrane not found V89.02 Suspected placental problem not found V89.03 Suspected fetal anomaly not found V89.04 Suspected problem with fetal growth not found V89.05 Suspected cervical shortening not found V89.09 Other suspected maternal and fetal condition not found E927.0 Overexertion from sudden strenuous movement E927.1 Overexertion from prolonged static position E927.2 Excessive physical exertion from prolonged activity E927.3 Cumulative trauma from repetitive motion E927.4 Cumulative trauma from repetitive impact E927.8 Other overexertion and strenuous and repetitive movements or loads E927.9 Unspecified overexertion and strenuous and repetitivemovements or loads

@wiki::95/ 2008-08-28 2008-08-28T16:08:50Z

Per American Academy of Professional Coders   New 2009 ICD-9-CM Codes 038.12 Methicillin resistant Staphylococcus aureus septicemia 041.12 Methicillin-resistant Staphylococcus aureus (MRSA) 046.11 Varient Creutzfeldt-Jakob disease 046.19 Other and unspecified Creutzfeldt-Jakob disease 046.71 Gerstmann-Sträussler-Scheinker syndrome 046.72 Fatal familial insomnia 046.79 Other and unspecified prion disease of central nervous system 051.01 Cowpox 051.02 Vaccinia not from vaccination 059.00 Orthopoxvirus infection, unspecified 059.01 Monkeypox 059.09 Other orthopoxvirus infections 059.10 Parapoxvirus infection, unspecified 059.11 Bovine stomatitis 059.12 Sealpox 059.19 Other parapoxvirus infections 059.20 Yatapoxvirus infection, unspecified 059.21 Tanapox 059.22 Yaba monkey tumor virus 059.8   Other poxvirus infections 059.9   Poxvirus infections, unspecified 078.12 Plantar wart 136.21 Specific infection due to acanthamoeba 136.29 Other specific infections by free-living amebae 199.2   Malignant neoplasm associated with transplant organ 203.02 Multiple myeloma, in relapse 203.12 Plasma cell leukemia, in relapse 203.82 Other immunoproliferative neoplasms, in relapse 204.02 Acute lymphoid leukemia, in relapse 204.12 Chronic lymphoid leukemia, in relapse 204.22 Subacute lymphoid leukemia, in relapse 204.82 Other lymphoid leukemia, in relapse 204.92 Unspecified lymphoid leukemia, in relapse 205.02 Acute myeloid leukemia, in relapse 205.12 Chronic myeloid leukemia, in relapse 205.22 Subacute myeloid leukemia, in relapse 205.32 Myeloid sarcoma, in relapse 205.82 Other myeloid leukemia, in relapse 205.92 Unspecified myeloid leukemia, in relapse 208.92 Unspecified leukemia, in relapse 206.02 Acute monocytic leukemia, in relapse 206.12 Chronic monocytic leukemia, in relapse 206.22 Subacute monocytic leukemia, in relapse 206.82 Other monocytic leukemia, in relapse 206.92 Unspecified monocytic leukemia, in relapse 207.02 Acute erythremia and erythroleukemia, in relapse 207.12 Chronic erythremia, in relapse 207.22 Megakaryocytic leukemia, in relapse 207.82 Other specified leukemia, in relapse 208.02 Acute leukemia of unspecified cell type, in relapse 208.12 Chronic leukemia of unspecified cell type, in relapse 208.22 Subacute leukemia of unspecified cell type, in relapse 208.82 Other leukemia of unspecified cell type, in relapse 209.00 Malignant carcinoid tumor of the small intestine, unspecified portion 209.01 Malignant carcinoid tumor of the duodenum 209.02 Malignant carcinoid tumor of the jejunum 209.03 Malignant carcinoid tumor of the ileum 209.10 Malignant carcinoid tumor of the large intestine, unspecified portion 209.11 Malignant carcinoid tumor of the appendix 209.12 Malignant carcinoid tumor of the cecum 209.13 Malignant carcinoid tumor of the ascending colon 209.14 Malignant carcinoid tumor of the transverse colon 209.15 Malignant carcinoid tumor of the descending colon 209.16 Malignant carcinoid tumor of the sigmoid colon 209.17 Malignant carcinoid tumor of the rectum 209.20 Malignant carcinoid tumor of unknown primary site 209.21 Malignant carcinoid tumor of the bronchus and lung 209.22 Malignant carcinoid tumor of the thymus 209.23 Malignant carcinoid tumor of the stomach 209.24 Malignant carcinoid tumor of the kidney 209.25 Malignant carcinoid tumor of foregut, NOS 209.26 Malignant carcinoid tumor of midgut, NOS 209.27 Malignant carcinoid tumor of hindgut, NOS 209.29 Malignant carcinoid tumor of other sites 209.30 Malignant poorly differentiated neuroendocrine carcinoma, any site 209.40 Benign carcinoid tumor of the small intestine, unspecified portion 209.41 Benign carcinoid tumor of the duodenum 209.42 Benign carcinoid tumor of the jejunum 209.43 Benign carcinoid tumor of the ileum 209.50 Benign carcinoid tumor of the large intestine, unspecified portion 209.51 Benign carcinoid tumor of the appendix 209.52 Benign carcinoid tumor of the cecum 209.53 Benign carcinoid tumor of the ascending colon 209.54 Benign carcinoid tumor of the transverse colon 209.55 Benign carcinoid tumor of the descending colon 209.56 Benign carcinoid tumor of the sigmoid colon 209.57 Benign carcinoid tumor of the rectum 209.60 Benign carcinoid tumor of unknown primary site 209.61 Benign carcinoid tumor of the bronchus and lung 209.62 Benign carcinoid tumor of the thymus 209.63 Benign carcinoid tumor of the stomach 209.64 Benign carcinoid tumor of the kidney 209.65 Benign carcinoid tumor of foregut, NOS 209.66 Benign carcinoid tumor of midgut, NOS 209.67 Benign carcinoid tumor of hindgut, NOS 209.69 Benign carcinoid tumor of other sites 238.77 Post-transplant lymphoproliferative disorder (PTLD) 249.00 Secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 249.01 Secondary diabetes mellitus without mention of complication, uncontrolled 249.10 Secondary diabetes mellitus with ketoacidosis, not stated as uncontrolled, or unspecified 249.11 Secondary diabetes mellitus with ketoacidosis, uncontrolled 249.20 Secondary diabetes mellitus with hyperosmolarity, not stated as uncontrolled, or unspecified 249.21 Secondary diabetes mellitus with hyperosmolarity, uncontrolled 249.30 Secondary diabetes mellitus with other coma, not stated as uncontrolled, or unspecified 249.31 Secondary diabetes mellitus with other coma, uncontrolled 249.40 Secondary diabetes mellitus with renal manifestations, not stated as uncontrolled, or unspecified 249.41 Secondary diabetes mellitus with renal manifestations, uncontrolled 249.50 Secondary diabetes mellitus with ophthalmic manifestations, not stated as uncontrolled, or unspecified 249.51 Secondary diabetes mellitus with ophthalmic manifestations, uncontrolled 249.60 Secondary diabetes mellitus with neurological manifestations, not stated as uncontrolled, or unspecified 249.61 Secondary diabetes mellitus with neurological manifestations, uncontrolled 249.70 Secondary diabetes mellitus with peripheral circulatory disorders, not stated as uncontrolled, or unspecified 249.71 Secondary diabetes mellitus with peripheral circulatory disorders, uncontrolled 249.80 Secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified 249.81 Secondary diabetes mellitus with other specified manifestations, uncontrolled 249.90 Secondary diabetes mellitus with unspecified complication, not stated as uncontrolled, or unspecified 249.91 Secondary diabetes mellitus with unspecified complication, uncontrolled 259.50 Androgen insensitivity, unspecified 259.51 Androgen insensitivity syndrome 259.52 Partial androgen insensitivity 275.5   Hungry bone syndrome 279.50 Graft-versus-host disease, unspecified 279.51 Acute graft-versus-host disease 279.52 Chronic graft-versus-host disease 279.53 Acute on chronic graft-versus-host disease 289.84 Heparin-induced thrombocytopenia (HIT) 337.00 Idiopathic peripheral autonomic neuropathy, unspecified 337.01 Carotid sinus syndrome 337.09 Other idiopathic peripheral autonomic neuropathy 339.00 Cluster headache syndrome, unspecified 339.01 Episodic cluster headache 339.02 Chronic cluster headache 339.03 Episodic paroxysmal hemicrania 339.04 Chronic paroxysmal hemicrania 339.05 Short lasting unilateral neuralgiform headache with conjunctival injection and tearing 339.09 Other trigeminal autonomic cephalgias 339.10 Tension type headache, unspecified 339.11 Episodic tension type headache 339.12 Chronic tension type headache 339.20 Post-traumatic headache, unspecified 339.21 Acute post-traumatic headache 339.22 Chronic post-traumatic headache 339.3   Drug induced headache, not elsewhere classified 339.41 Hemicrania continua 339.42 New daily persistent headache 339.43 Primary thunderclap headache 339.44 Other complicated headache syndrome 339.81 Hypnic headache 339.82 Headache associated with sexual activity 339.83 Primary cough headache 339.84 Primary exertional headache 339.85 Primary stabbing headache 339.89 Other headache syndromes 346.02 Migraine with aura, without mention of intractable migraine with status migrainosus 346.03 Migraine with aura, with intractable migraine, so stated, with status migrainosus 346.12 Migraine without aura, without mention of intractable migraine with status migrainosus 346.13 Migraine without aura, with intractable migraine, so stated, with status migrainosus 346.22 Variants of migraine, not elsewhere classified, without mention of intractable migraine with status migrainosus 346.23 Variants of migraine, not elsewhere classified, with intractable migraine, so stated, with status migrainosus 346.30 Hemiplegic migraine, without mention of intractable migraine without mention of status migrainosus 346.31 Hemiplegic migraine, with intractable migraine, so stated, without mention of status migrainosus 346.32 Hemiplegic migraine, without mention of intractable migraine with status migrainosus 346.33 Hemiplegic migraine, with intractable migraine, so stated, with status migrainosus 346.40 Menstrual migraine, without mention of intractable migraine without mention of status migrainosus 346.41 Menstrual migraine, with intractable migraine, so stated, without mention of status migrainosus 346.42 Menstrual migraine, without mention of intractable migraine with status migrainosus 346.43 Menstrual migraine, with intractable migraine, so stated, with status migrainosus 346.50 Persistent migraine aura without cerebral infarction, without mention of intractable migraine without mention of status migrainosus 346.51 Persistent migraine aura without cerebral infarction, with intractable migraine, so stated, without mention of status migrainosus 346.52 Persistent migraine aura without cerebral infarction, without mention of intractable migraine with status migrainosus 346.53 Persistent migraine aura without cerebral infarction, with intractable migraine, so stated, with status migrainosus 346.60 Persistent migraine aura with cerebral infarction, without mention of intractable migraine without mention of status migrainosus 346.61 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, without mention of status migrainosus 346.62 Persistent migraine aura with cerebral infarction, without mention of intractable migraine with status migrainosus 346.63 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, with status migrainosus 346.70 Chronic migraine without aura, without mention of intractable migraine without mention of status migrainosus 346.71 Chronic migraine without aura, with intractable migraine, so stated, without mention of status migrainosus 346.72 Chronic migraine without aura, without mention of intractable migraine with status migrainosus 346.73 Chronic migraine without aura, with intractable migraine, so stated, with status migrainosus 346.82 Other forms of migraine, without mention of intractable migraine with status migrainosus 346.83 Other forms of migraine, with intractable migraine, so stated, with status migrainosus 346.92 Unspecified migraine, without mention of intractable migraine with status migrainosus 346.93 Unspecified migraine, with intractable migraine, so stated, with status migrainosus 362.20 Retinopathy of prematurity, unspecified 362.22 Retinopathy of prematurity, stage 0 362.23 Retinopathy of prematurity, stage 1 362.24 Retinopathy of prematurity, stage 2 362.25 Retinopathy of prematurity, stage 3 362.26 Retinopathy of prematurity, stage 4 362.27 Retinopathy of prematurity, stage 5 364.82 Plateau iris syndrome 372.34 Pingueculitis 414.3   Coronary atherosclerosis due to lipid rich plaque 511.81 Malignant pleural effusion 511.89 Other specified forms of effusion, except tuberculous 530.13 Eosinophilic esophagitis 535.70 Eosinophilic gastritis without mention of hemorrhage 535.71 Eosinophilic gastritis with hemorrhage 558.41 Eosinophilic gastroenteritis 558.42 Eosinophilic colitis 569.44 Dysplasia of anus 571.42 Autoimmune hepatitis 599.70 Hematuria, unspecified 599.71 Gross hematuria 599.72 Microscopic hematuria 611.81 Ptosis of breast 611.82 Hypoplasia of breast 611.83 Capsular contracture of breast implant 611.89 Other specified disorders of breast 612.0 Deformity of reconstructed breast 612.1 Disproportion of reconstructed breast 625.70 Vulvodynia, unspecified 625.71 Vulvar vestibulitis 625.79 Other vulvodynia 649.70 Cervical shortening, unspecified as to episode of care or not applicable 649.71 Cervical shortening, delivered, with or without mention of antepartum condition 649.73 Cervical shortening, antepartum condition or complication 678.00 Fetal hematologic conditions, unspecified as to episode of care or not applicable 678.01 Fetal hematologic conditions, delivered, with or without mention of antepartum condition 678.03 Fetal hematologic conditions, antepartum condition or complication   678.10 Fetal conjoined twins, unspecified as to episode of care or not applicable 678.11 Fetal conjoined twins, delivered, with or without mention of antepartum condition 678.13 Fetal conjoined twins, antepartum condition or complication 679.00 Maternal complications from in utero procedure, unspecified as to episode of care or not applicable 679.01 Maternal complications from in utero procedure, delivered, with or without mention of antepartum condition 679.02 Maternal complications from in utero procedure, delivered, with mention of postpartum complication 679.03 Maternal complications from in utero procedure, antepartum condition or complication 679.04 Maternal complications from in utero procedure, postpartum condition or complication 679.10 Fetal complications from in utero procedures, unspecified as to episode of care or not applicable 679.11 Fetal complications from in utero procedures, delivered, with or without mention of antepartum condition 679.12 Fetal complications from in utero procedures, delivered, with mention of postpartum complication 679.13 Fetal complications from in utero procedures, antepartum condition or complication 679.14 Fetal complications from in utero procedures, postpartum condition or complication 695.10 Erythema multiforme, unspecified 695.11 Erythema multiforme minor 695.12 Erythema multiforme major 695.13 Stevens-Johnson syndrome 695.14 Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome 695.15 Toxic epidermal necrolysis 695.19 Other erythema multiforme 695.50 Exfoliation due to erythematous condition involving less than 10 percent of body surface 695.51 Exfoliation due to erythematous condition involving 10-19 percent of body surface 695.52 Exfoliation due to erythematous condition involving 20-29 percent of body surface 695.53 Exfoliation due to erythematous condition involving 30-39 percent of body surface 695.54 Exfoliation due to erythematous condition involving 40-49 percent of body surface 695.55 Exfoliation due to erythematous condition involving 50-59 percent of body surface 695.56 Exfoliation due to erythematous condition involving 60-69 percent of body surface 695.57 Exfoliation due to erythematous condition involving 70-79 percent of body surface 695.58 Exfoliation due to erythematous condition involving 80-89 percent of body surface 695.59 Exfoliation due to erythematous condition involving 90 percent or more of body surface 707.20 Pressure ulcer, unspecified stage 707.21 Pressure ulcer, stage I 707.22 Pressure ulcer, stage II 707.23 Pressure ulcer, stage III 707.24 Pressure ulcer, stage IV 707.25 Pressure ulcer, unstageable 729.90 Disorders of soft tissue, unspecified 729.91 Post-traumatic seroma 729.92 Nontraumatic hematoma of soft tissue 729.99 Other disorders of soft tissue 760.61 Newborn affected by amniocentesis 760.62 Newborn affected by other in utero procedure 760.63 Newborn affected by other surgical operations on mother during pregnancy 760.64 Newborn affected by previous surgical procedure on mother not associated with pregnancy 777.50 Necrotizing enterocolitis in newborn, unspecified 777.51 Stage I necrotizing enterocolitis in newborn 777.52 Stage II necrotizing enterocolitis in newborn 777.53 Stage III necrotizing enterocolitis in newborn 780.60 Fever, unspecified 780.61 Fever presenting with conditions classified elsewhere 780.62 Postprocedural fever 780.63 Postvaccination fever 780.64 Chills (without fever) 780.65 Hypothermia not associated with low environmental temperature 780.72 Functional quadriplegia 788.91 Functional urinary incontinence 788.99 Other symptoms involving urinary system 795.07 Satisfactory cervical smear but lacking transformation zone 795.10 Abnormal glandular Papanicolaou smear of vagina 795.11 Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US) 795.12 Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H) 795.13 Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL) 795.14 Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL) 795.15 Vaginal high risk human papillomavirus (HPV) DNA test positive 795.16 Papanicolaou smear of vagina with cytologic evidence of malignancy 795.18 Unsatisfactory vaginal cytology smear 795.19 Other abnormal Papanicolaou smear of vagina and vaginal HPV 796.70 Abnormal glandular Papanicolaou smear of anus 796.71 Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US) 796.72 Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H) 796.73 Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL) 796.74 Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL) 796.75 Anal high risk human papillomavirus (HPV) DNA test positive 796.76 Papanicolaou smear of anus with cytologic evidence of malignancy 796.77 Satisfactory anal smear but lacking transformation zone 796.78 Unsatisfactory anal cytology smear 796.79 Other abnormal Papanicolaou smear of anus and anal HPV 997.31 Ventilator associated pneumonia 997.39 Other respiratory complications 998.30 Disruption of wound, unspecified 998.33 Disruption of traumatic wound repair 999.81 Extravasation of vesicant chemotherapy 999.82 Extravasation of other vesicant agent 999.88 Other infusion reaction 999.89 Other transfusion reaction V02.53 Methicillin susceptible Staphylococcus aureus MSSA colonization V02.54 Methicillin resistant Staphylococcus aureus MRSA colonization V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs) V07.52 Prophylactic use of aromatase inhibitors V07.59 Prophylactic use of other agents affecting estrogen receptors and estrogen levels V12.04 Methicillin resistant Staphylococcus aureus V13.51 Personal history of pathologic fracture V13.52 Personal history of stress fracture V13.59 Personal history of other musculoskeletal disorders V15.21 Personal history of undergoing in utero procedure during pregnancy V15.22 Personal history of undergoing in utero procedure while a fetus V15.29 Personal history of surgery to other organs V15.51 Personal history of traumatic fracture V15.59 Personal history of other injury V23.85 Pregnancy resulting from assisted reproductive technology V23.86 Pregnancy with history of in utero procedure during previous pregnancy V28.81 Encounter for fetal anatomic survey V28.82 Encounter for screening for risk of pre-term labor V28.89 Other specified antenatal screening V45.11 Renal dialysis status V45.12 Noncompliance with renal dialysis V45.87 Transplanted organ removal status V45.88 Status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility V46.3 Wheelchair dependence V51.0   Encounter for breast reconstruction following mastectomy V51.8   Other aftercare involving the use of plastic surgery V61.01 Family disruption due to family member on military deployment             Individual or family affected by other family member being on deployment V61.02 Family disruption due to return of family member from military deployment             Individual or family affected by other family member having returned from deployment (current or past conflict) V61.03 Family disruption due to divorce or legal separation V61.04 Family disruption due to parent-child estrangement V61.05 Family disruption due to child in welfare custody V61.06 Family disruption due to child in foster care or in care of non-parental family member V61.09 Other family disruption V62.21 Personal current military deployment status V62.22 Personal history of return from military deployment V62.29 Other occupational circumstances or maladjustment V87.01 Contact with and (suspected) exposure to arsenic V87.09 Contact with and (suspected) exposure to other hazardous metals V87.11 Contact with and (suspected) exposure to aromatic amines V87.12 Contact with and (suspected) exposure to benzene V87.19 Contact with and (suspected) exposure to other hazardous aromatic compounds V87.2   Contact with and (suspected) exposure to other potentially hazardous chemicals V87.3   Contact with and (suspected) exposure to other potentially hazardous substances V87.31 Contact with and (suspected) exposure to mold V87.39 Contact with and (suspected) exposure to other potentially hazardous substances V87.41 Personal history of antineoplastic chemotherapy V87.42 Personal history of monoclonal drug therapy V87.49 Personal history of other drug therapy V88.01 Acquired absence of both cervix and uterus V88.02 Acquired absence of uterus with remaining cervical stump V88.03 Acquired absence of cervix with remaining uterus V89.01 Suspected problem with amniotic cavity and membrane not found V89.02 Suspected placental problem not found V89.03 Suspected fetal anomaly not found V89.04 Suspected problem with fetal growth not found V89.05 Suspected cervical shortening not found V89.09 Other suspected maternal and fetal condition not found E927.0 Overexertion from sudden strenuous movement E927.1 Overexertion from prolonged static position E927.2 Excessive physical exertion from prolonged activity E927.3 Cumulative trauma from repetitive motion E927.4 Cumulative trauma from repetitive impact E927.8 Other overexertion and strenuous and repetitive movements or loads E927.9 Unspecified overexertion and strenuous and repetitivemovements or loads  

@wiki::94/ 2008-08-04 2008-08-04T15:35:01Z

  Tiers Tier 4 Drugs and the Fraying of the Social Compact (NEJM, July 24, 2008)

@wiki::93/ 2008-07-14 2008-07-14T03:15:29Z

  Final Rules OPPS [CMS-1206-FC] - November 1, 2002 [Fed Reg PDF]

@wiki::92/ 2008-07-14 2008-07-14T02:51:52Z

  Final Rules OPPS Final Rule [CMS-1159-F2] - CMS copy

@wiki::91/ 2008-07-11 2008-08-13T01:38:08Z

The inpatient list specifies those services that are only paid when provided in an inpatient setting because of the nature of the procedure, the need for at least 24 hours of postoperative recovery time or monitoring before the patient can be safely discharged, or the underlying physical condition of the patient. [65 FR 18455] Timeline Introduced (April 7, 2000 final rule with comment period) -- 65 FR 18455 Criteria developed (November 30, 2001 final rule) -- 66 FR 59856 Criteria for removing from list and assigning to APC group: November 30, 2001 final rule (66 FR 59856) Most outpatient departments are equipped to provide the services to the Medicare population. The simplest procedure described by the code may be performed in most outpatient departments. The procedure is related to codes that we have already removed from the inpatient list. November 1, 2002 final rule with comment period (67 FR 66741) We have determined that the procedure is being performed in numerous hospitals on an outpatient basis; or We have determined that the procedure can be appropriately and safely performed in an ASC, and is on the list of approved ASC procedures or has been proposed by us for addition to the ASC list. List of codes on Inpatient List typically provided as Addendum E on OPPS proposed rule.  

@wiki::90/ 2008-07-01 2008-07-01T05:48:47Z

Bilateral Surgeries and CPT Modifier 50 Background Reimbursement for bilateral surgeries is determined using the Medicare Physician Fee Schedule Database (MPFSDB). The MPFSDB defines procedures that may be submitted as “bilateral” and how reimbursement is calculated. The “bilateral surgery indicator” in the MPFSDB indicates how the bilateral surgery must be submitted to Medicare. To access this database, refer to the CMS Web site at: http://www.cms.hhs.gov/Pfslookup. The concept of a “bilateral surgery” applies when a procedure is performed on both sides of the body during the same operative session or on the same day.   Bilateral Surgery Indicators and Claim Submission Bilateral Surgery Indicator Payment Basis Claim Submission 0 The lower of the actual submitted charge for both procedures or 100% of the fee schedule amount for a single procedure. Payment is not increased for these procedures because physiology or anatomy are not appropriate (e.g., surgeries on the large intestine), or because the code descriptor specifies that it is a unilateral procedure and there is an existing code for a bilateral procedure. Submit the surgery with a quantity of “1.” Do not submit these procedures with CPT modifier 50. 1 The lower of the actual submitted charge or 150% of the fee schedule amount. Submit the surgery on a single detail line with CPT modifier 50 and a quantity of “1.” Option: submit the surgery on 2 detail lines, one with HCPCS modifier RT and one with HCPCS modifier LT. Tip: check any applicable Local Coverage Determinations (LCDs) for additional information on HCPCS modifiers RT and LT. 2 The lower of the actual submitted charge for both procedures or 100% of the fee schedule amount for a single procedure. The fee schedule amount is already based on the procedure being performed bilaterally. The fee schedule takes into account the bilateral nature of these procedures because the code descriptor states that a) the procedure is bilateral, b) the procedure may be performed unilaterally or bilaterally, or c) the procedure is usually performed as a bilateral procedure. Submit the surgery with a quantity of “1.” Do not submit these procedures with CPT modifier 50. 3 The lower of the actual submitted charge for both procedures or 100% of the fee schedule amount for each side. Most procedures with a bilateral surgery indicator of “3” are radiology procedures or other diagnostic tests, which are not subject to the special payment rules for other bilateral procedures. Submit the surgery (or procedure) on a single detail line with CPT modifier 50 and a quantity of “2.” Option: submit the surgery on 2 detail lines, one with HCPCS modifier RT and one with HCPCS modifier LT. 9 The concept of “bilateral surgery” does not apply. Submit the surgery (or procedure) with a quantity of “1.” Do not submit these procedures with CPT modifier 50. Reference www.cms.hhs.gov/manuals/download/Clm104c12.pdf: CMS Medicare Claims Processing Manual (Pub. 100-04): Chapter 12, Section 40.7

@wiki::89/ 2008-06-29 2008-06-29T20:58:27Z

FACILITY BASED PAYMENT DIFFERENTIAL There are different fee rates for non-facility and facility services. Facility rates apply to professional services performed in a facility other than the professional's office. Non-facility rates apply when the service is performed in the professional's office. The non-facility rate accommodates overhead and indirect expenses the provider incurs by operating the provider's own office. Thus the reimbursement is somewhat higher than the facility rate.